Abstract | OBJECTIVES: METHODS AND RESULTS:
Propidium iodide (PI) exclusion was used to assess survival. Diazoxide treatment conferred protection against LSI/R (13.9+/-0.9% vs. 36.9+/-4.5% controls) that was abolished by pre-treatment with the mitoK(ATP) channel blocker, 5-hydroxydecanoate (5-HD) (33.3+/-3.6%) and with the free radical scavenger, 2-mercaptopropionylglycine (MPG) (29+/-4.0%). Diazoxide caused increased oxidation of the ROS probe, reduced mitotracker orange (1.3 vs. 1.0 arbitrary units for control; P<0.01 vs. control) that was abrogated by either 5-HD or MPG (1.07 and 1.07 arbitrary units, respectively). At the same time there was no change in orange fluorescent signal from the membrane potential sensitive probe, JC-1 indicating no change in mitochondrial membrane potential. Changes in light scattering, reflecting changes in mitochondrial volume, occurred during treatment with diazoxide. CONCLUSION: These results demonstrate for the first time that the mitoK(ATP) channel opener diazoxide can act as a trigger of preconditioning by a mechanism involving mitochondrial swelling and the generation of ROS.
|
Authors | R Carroll, V A Gant, D M Yellon |
Journal | Cardiovascular research
(Cardiovasc Res)
Vol. 51
Issue 4
Pg. 691-700
(Sep 2001)
ISSN: 0008-6363 [Print] England |
PMID | 11530102
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Arrhythmia Agents
- Decanoic Acids
- Free Radical Scavengers
- Hydroxy Acids
- Potassium Channels
- Reactive Oxygen Species
- 5-hydroxydecanoic acid
- Tiopronin
- Diazoxide
|
Topics |
- Analysis of Variance
- Anti-Arrhythmia Agents
(pharmacology)
- Cell Line
- Decanoic Acids
(pharmacology)
- Diazoxide
(pharmacology)
- Flow Cytometry
- Free Radical Scavengers
(pharmacology)
- Heart Atria
- Humans
- Hydroxy Acids
(pharmacology)
- Ion Channel Gating
- Ischemic Preconditioning, Myocardial
- Membrane Potentials
(drug effects)
- Microscopy, Fluorescence
- Mitochondria, Heart
(drug effects, metabolism, ultrastructure)
- Potassium Channels
(drug effects)
- Reactive Oxygen Species
(metabolism)
- Tiopronin
(pharmacology)
|